These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14643978)

  • 1. Effect of poly-hydroxy aliphatic ester polymer type on amoxycillin release from cylindrical compacts.
    Mollo AR; Corrigan OI
    Int J Pharm; 2003 Dec; 268(1-2):71-9. PubMed ID: 14643978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the mechanism of release of the amphoteric drug amoxycillin from poly(D,L-lactide-co-glycolide) matrices.
    Mollo AR; Corrigan OI
    Pharm Dev Technol; 2002; 7(3):333-43. PubMed ID: 12229265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
    Ozalp Y; Ozdemir N; Hasirci V
    J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
    Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
    J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
    Kranz H; Ubrich N; Maincent P; Bodmeier R
    J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation.
    Ahuja A; Ali J; Rahman S
    Pharmazie; 2006 Jan; 61(1):25-9. PubMed ID: 16454202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis.
    Zhang Y; Zale S; Sawyer L; Bernstein H
    J Biomed Mater Res; 1997 Mar; 34(4):531-8. PubMed ID: 9054536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.
    Chen S; Singh J
    Pharm Dev Technol; 2005; 10(2):319-25. PubMed ID: 15926681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Printability and Critical Insight into Polymer Properties during Direct-Extrusion Based 3D Printing of Medical Grade Polylactide and Copolyesters.
    Jain S; Fuoco T; Yassin MA; Mustafa K; Finne-Wistrand A
    Biomacromolecules; 2020 Feb; 21(2):388-396. PubMed ID: 31566357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
    Clarke N; O'Connor K; Ramtoola Z
    Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
    Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
    J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers.
    Schmitt EA; Flanagan DR; Linhardt RJ
    J Pharm Sci; 1993 Mar; 82(3):326-9. PubMed ID: 8450430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma irradiation for terminal sterilization of 17beta-estradiol loaded poly-(D,L-lactide-co-glycolide) microparticles.
    Mohr D; Wolff M; Kissel T
    J Control Release; 1999 Aug; 61(1-2):203-17. PubMed ID: 10469916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
    Jain RA
    Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.